EGFR and breast cancer: Our present data are in line with the earlier publication by Franovic et al. showing that HIF2α confers growth factor-independent proliferation to numerous cancers, including breast cancer, regardless of their tissue of origin or mutational status and that the proliferative effect was exerted via receptor tyrosine kinases, including EGFR [33].